ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft survival"

  • 2020 American Transplant Congress

    The Effect of Desensitization Therapy on Sex Disparity in Living Kidney Transplantation

    Y. Kakuta1, M. Okumi1, T. Kanzawa1, K. Unagami2, H. Ishida2, K. Tanabe1

    1Urology, Tokyo Women's Medical University, Tokyo, Japan, 2Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan

    *Purpose: Sex- and gender-based disparities which have shown women to have lower access to kidney transplantation have been reported. In living kidney transplantation (LKT), pregnancy-related…
  • 2020 American Transplant Congress

    TRANSFORM Study (NCT01950819): Application of the Ibox Clinical Trial Simulation Tool to Project Long-Term Kidney Allograft Outcome

    G. Divard1, O. Aubert1, M. Raynaud1, J. Pascual2, F. Vincenti3, P. Bernhardt4, C. Legendre1, A. Loupy1, .. on behalf of TRANSFORM Investigators5

    1INSERM U970, Paris Transplant Group, Paris, France, 2Department of Nephrology, Hospital del Mar/Universitat Autònoma de Barcelona, Barcelona, Spain, 3Department of Surgery/Kidney Transplant Service, University of California, San Francisco, CA, 4Research and Development, Novartis Pharma AG, Basel, Switzerland, 5TRANSFORM Investigators, Basel, Switzerland

    *Purpose: The development of pharmaceutical agents in transplantation is currently limited by long waits for hard endpoints. We sought to use a risk stratification system…
  • 2020 American Transplant Congress

    Post-Transplant Hepatic CHOP Expression Dictates Clinical Outcomes in Liver Transplantation

    H. Hirao1, T. Ito1, K. Nakamura2, S. Kageyama1, K. Kadono1, H. Kojima1, K. J. Dery1, S. Younan1, R. W. Busuttil1, F. M. Kaldas1, J. W. Kupiec‐Weglinski1

    1UCLA, Los Angeles, CA, 2Kyoto University, Kyoto, Japan

    *Purpose: Endoplasmic reticulum (ER) stress plays a pivotal role in the mechanism of liver ischemia reperfusion injury (IRI). Although we and others have demonstrated the…
  • 2020 American Transplant Congress

    Early Calculation of the Tacrolimus Concentration-to-Dose Ratio Does Not Predict Outcomes after Renal Transplantation

    K. Schütte-Nütgen, I. Bartmann, B. Suwelack, S. Reuter

    Department of Internal Medicine D, University Hospital Münster, Münster, Germany

    *Purpose: There is emerging interest in the concentration-to-dose (C/D) ratio of tacrolimus (Tac) as it is linked to outcomes after renal transplantation (RTx). Recently, we…
  • 2020 American Transplant Congress

    Donor and Recipient Sex Affect Transplant Outcomes in an Age-Specific Fashion

    R. Maenosono1, Y. Nian1, J. Iske1, Y. Liu1, H. Azuma2, E. Milford3, S. G. Tullius1

    1Division of Transplant Surgery, Brigham and Women's Hospital, Boston, MA, 2Urology, Osaka Medical College, Osaka, Japan, 3Renal Division, Brigham and Women's Hospital, Boston, MA

    *Purpose: Donor and recipient sex impact transplant outcomes. The biology of sex-specific alloimmune responses has not been studied in detail.*Methods: Using clinical data from more…
  • 2020 American Transplant Congress

    Steroid Dependence at 1 Yr in Kidney Transplant Recipients Initiated on Early Steroid Withdrawal Protocol: Associated Risk Factors and Prognosis

    M. Yaqub, D. Mishler, T. Taber, A. Sharfuddin, W. Goggins, O. Adebiyi

    Indiana University, Indianapolis, IN

    *Purpose: Early steroid withdrawal (ESW) has become a stable immunosuppression regimen in the USA with a third of patients now discharged steroid-free immediately post-transplant. However,…
  • 2020 American Transplant Congress

    Bone Marrow Mesenchymal Stem Cells Improve Rat Islet Angiogenesis by Upregulating of ISL1 and VEGF-A

    Y. Wang1, J. Wang2, X. Ding2

    1Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, China, 2Department of Renal Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China

    *Purpose: Islet transplantation is an important therapy to cure diabetes, but poor angiogenesis in the early stage of islet transplantation is one of the main…
  • 2020 American Transplant Congress

    Atrial Fibrillation Predicts Inferior Survival in Liver Transplant Recipients of Advanced Age in a Large Multicenter U.S. Cohort

    M. German1, A. Hristov1, A. Lee1, F. Osman1, A. Kwong2, D. Devuni3, C. Wang4, J. Boike5, J. Jo5, L. VanWagner5, M. Serper6, R. Sharma7, E. Verna7, J. Shor3, A. Koteish8, G. Sehmbey9, A. Seetharam9, N. John2, Y. Patel10, M. Kappus10, T. Couri11, S. Paul11, R. Salgia12, Q. Nhu13, C. Frenette13, J. Lai4, A. Goel2, E. Spengler1

    1U of Wisconsin, Madison, WI, 2Stanford, Palo Alto, CA, 3U of Massachusetts, Worcester, MA, 4U of California, San Francisco, CA, 5Northwestern, Chicago, IL, 6U of Pennsylvania, Philadelphia, PA, 7Columbia, New York, NY, 8Florida Hospital, Orlando, FL, 9U of Arizona, Phoenix, AZ, 10Duke, Durham, NC, 11U of Chicago, Chicago, IL, 12Henry Ford Hospital, Detroit, MI, 13Scripps, San Diego, CA

    *Purpose: More liver transplants (LT) are being performed in patients >65 years (y) - a population with higher rates of cardiovascular (CV) disease. It is…
  • 2020 American Transplant Congress

    Liver Transplantation from Donors after Circulatory Death Using “tPA”Protocol: The University of Miami Experience

    R. Vianna, A. Farag, G. Selvaggi, A. Tekin, W. De Faria, M. Morsi, R. Miyashiro, T. Beduschi

    University of Miami, Miami Transplant Institute, Miami, FL

    *Purpose: Expansion of liver transplantation (LT) from donors after circulatory death (DCD) has been increasingly used to overcome the persistent organ shortage and long waiting…
  • 2020 American Transplant Congress

    Graft Survival after Liver Transplantation for Patients with Cholangiocarcinoma

    I. A. Ziogas, L. A. Hickman, L. K. Matsuoka, M. I. Montenovo, M. Izzy, S. A. Rega, I. D. Feurer, S. P. Alexopoulos

    Vanderbilt University Medical Center, Nashville, TN

    *Purpose: Liver transplantation (LT) with neoadjuvant chemoradiation is increasingly utilized for the treatment for unresectable cholangiocarcinoma (CCA), however, post-LT graft survival is not well described.…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 113
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences